Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival.
暂无分享,去创建一个
Howard Y. Chang | Yudong D. He | R. Tibshirani | T. Hastie | P. Brown | M. van de Rijn | T. Sørlie | M. J. van de Vijver | L. V. van't Veer | H. Bartelink | H. Dai | D. Nuyten | Julie B. Sneddon | L. V. van‘t Veer | L. V. van’t Veer | Yudong He
[1] AC Tose. Cell , 1993, Cell.
[2] Mike Clarke,et al. Polychemotherapy for early breast cancer: an overview of the randomised trials , 1998, The Lancet.
[3] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[4] J. Mesirov,et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.
[5] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[6] Ash A. Alizadeh,et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.
[7] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[8] C. Isaacs,et al. New prognostic factors for breast cancer recurrence. , 2001, Seminars in oncology.
[9] Robert J. Mayer,et al. National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000. , 2001, Journal of the National Cancer Institute.
[10] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[11] Yudong D. He,et al. A Gene-Expression Signature as a Predictor of Survival in Breast Cancer , 2002 .
[12] M. West,et al. Gene expression predictors of breast cancer outcomes , 2003, The Lancet.
[13] M. West,et al. Gene expression phenotypic models that predict the activity of oncogenic pathways , 2003, Nature Genetics.
[14] T. Golub,et al. A Mechanism of Cyclin D1 Action Encoded in the Patterns of Gene Expression in Human Cancer , 2003, Cell.
[15] E. Lander,et al. A molecular signature of metastasis in primary solid tumors , 2003, Nature Genetics.
[16] Barbara L. Smith,et al. Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] R. Tibshirani,et al. Repeated observation of breast tumor subtypes in independent gene expression data sets , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[18] R. Gelber,et al. Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] C. Hudis,et al. Adjuvant therapy for breast cancer: practical lessons from the early breast cancer trialists' collaborative group. , 2004, Breast disease.
[20] Ash A. Alizadeh,et al. Gene Expression Signature of Fibroblast Serum Response Predicts Human Cancer Progression: Similarities between Tumors and Wounds , 2004, PLoS biology.
[21] R. Tibshirani,et al. Gene expression profiling identifies clinically relevant subtypes of prostate cancer. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[22] M. Stockler,et al. Systematic review of taxane-containing versus non-taxane-containing regimens for adjuvant and neoadjuvant treatment of early breast cancer. , 2004, The Lancet. Oncology.